Linus Health Marks Milestone with Extensive Research Findings in Cognitive Health

Linus Health’s Research Journey and Innovations in Cognitive Health

Linus Health, a frontrunner in digital health solutions, has reached a significant milestone by achieving recognition with over 145 peer-reviewed studies. These publications, authored by experts within the company and its affiliates, mark a concerted effort to enhance understanding and treatment options for cognitive impairment, particularly in relation to Alzheimer’s disease and other dementias.

Since its inception in 2019, Linus Health has consistently focused on developing science-driven solutions that enable early detection and intervention in brain health. The company has published 72 peer-reviewed papers and organized 75 scientific presentations at academic conferences, showcasing its commitment to research and clinical excellence.

Revolutionizing Brain Health

Linus Health is reshaping the landscape of cognitive health through its comprehensive platform designed to identify early indicators of cognitive impairment. Research conducted under its banner has validated the effectiveness and precision of various elements within the system, significantly increasing the potential for early intervention and ongoing care across diverse clinical settings.

Among the many notable studies is one published in the Journal of Alzheimer’s Disease, which explored the effectiveness of the Digital Clock and Recall (DCR™) assessment in identifying functional impairments. The results underscored the DCR’s capability to guide healthcare providers in recognizing patients who require advanced diagnostic testing or specialized referrals, facilitating timely care interventions.

Further research highlighted the efficiency of Linus Health’s digital hearing screening tool, as illustrated in publications like Scientific Reports. This study affirmed that the new mobile assessment could swiftly and accurately detect early speech hearing impairments — a crucial step in broadening the understanding of cognitive health.

Commitment to Clinical Validation

Linus Health has not only completed 40 clinical trials and 25 validation studies, but it has also filed for 33 patents to protect its innovative technologies. This approach signifies a deep dedication to scientific validation, ensuring that the company's advancement in brain health is rooted in robust evidence and research findings.

The dedication to quality and innovation is echoed by Alvaro Pascual-Leone, MD, PhD, Co-Founder and Chief Medical Officer of Linus Health, who stated, "These landmark achievements reflect Linus Health's unwavering dedication to scientific validation as we scale and enhance our offerings and capabilities." This statement encapsulates the company’s ethos of advancing healthcare from lab to patient bedside, prioritizing real-world applications of its research innovations.

Expansion and Recognition

In recent years, Linus Health has expanded its influence significantly within the health tech industry, completing four key acquisitions since 2020, bolstering its capabilities in cognitive assessment and brain health solutions. The acquisition of Aural Analytics, known for its excellence in clinical-grade speech analytics, marks one of the latest strategic expansions.

Recognition also comes from various prestigious awards. For instance, Linus Health was named one of Fierce Healthcare's Fierce 15 in 2025 and achieved the title of “Best in Class” in the Digital Health Awards 2024 within the Longevity category. These accolades reflect the company’s potential to reshape healthcare systems through innovative practices and technologies.

Advocacy for Early Detection

Linus Health continues to champion the importance of early detection in the fight against dementia. At major conferences like the HLTH Event 2024 in Las Vegas, John Showalter, MD, discussed leveraging digital tools for primary care physicians and neurologists to identify mild cognitive impairments early — thus normalizing preventative care as part of routine health check-ups. Furthermore, significant presentations at conferences such as the Alzheimer’s Association International Conference (AAIC) further affirmed Linus Health’s commitment to disseminating knowledge and research developments to a global audience.

Future Directions

The progression of Linus Health signifies a promising shift towards improving brain health through proactive interventions. David Bates, PhD, Co-Founder and CEO, emphasizes that these achievements signal an evolving consensus around the necessity of promoting brain health and preventing cognitive decline through lifestyle modifications and early detection practices.

Linus Health aims to empower providers and patients alike by providing actionable insights and personalized care plans designed to enhance the quality of life for individuals dealing with cognitive challenges. With its ongoing commitment to research and its innovative approach, Linus Health is poised to redefine the future of cognitive healthcare.

For more information on Linus Health's solutions and advancements in brain health, visit Linus Health.